Unaudited Consolidated Condensed Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 13,177,625	$ 2,045,167
Accounts receivable	24	7,798
Inventory	181,496	105,650
Prepaid expenses	38,632	29,625
Deposits	7,590	7,590
Total Current Assets	13,405,367	2,195,830
Equipment (net of $67,312 and $64,106 depreciation, respectively)	3,975	7,061
TOTAL ASSETS	13,409,342	2,202,891
Current Liabilities:
Accounts payable and accrued expenses	95,234	42,942
Interest payable	0	48,287
Total Current Liabilities	95,234	91,229
Long-term portion of notes payable	0	1,900,000
TOTAL LIABILITIES	95,234	1,991,229
SHAREHOLDERS' EQUITY
Preferred stock, Series B $0.10 par value per share; Authorized 1,000,000 shares; Issued and outstanding 10,000 and 1,000,000 shares as of March 31, 2022 and December 31, 2021, respectively.	1,000	100,000
Common Stock, $0.001 per share; Authorized 3,000,000,000 Shares; Issued and outstanding 7,149,778 and 2,591,240 shares as of March 31, 2022 and December 31, 2021, respectively	7,150	2,591
Capital paid in excess of par value	47,219,498	32,787,384
Accumulated comprehensive income (loss)	(22,132)	(23,139)
Accumulated (Deficit)	(33,891,408)	(32,655,174)
TOTAL SHAREHOLDERS' EQUITY	13,314,108	211,662
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 13,409,342	$ 2,202,891